Substandard and falsified medicines kill patients, yet progress on the twin challenges of safeguarding the quality of genuine medicine and criminalising falsified ones has been held back by controversy over intellectual property rights and confusion over terms. Amir Attaran and colleagues propose a global treaty to overcome the problems
No takes yet. Share an insight, caveat, or question.
Attaran et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: